Jisaixin (filgrastim biosimilar)
/ North China Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 13, 2019
Recombinant Human Serum Albumin/Granulocyte Colony Stimulating Factor Fusion Protein for Breast Cancer Patients
(clinicaltrials.gov)
- P2b; N=80; Completed; Sponsor: Tianjin SinoBiotech Ltd.; Recruiting ➔ Completed
Trial completion
1 to 1
Of
1
Go to page
1